Our labs are pioneering research in cancer and inflammatory diseases, focusing on the intricate interplay between microbes, the immune system, and cellular environments. Our studies explore how microbial pathogens and the host microbiome influence tumor development, progression, and response to therapy, as well as their role in triggering and modulating chronic inflammatory conditions. By leveraging cutting-edge techniques in molecular biology, immunology, and genomics, our researchers aim to uncover novel biomarkers and therapeutic targets, paving the way for innovative treatments that address the underlying microbial and immune mechanisms driving these complex diseases.
